Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-066702

Director bought 20,000 shares at $12.54 ($250,800)

From the SEC's structured data for this filing

Trades in this filing

Manning Paul B · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-23 Purchase : show line 1 in the form +20,000 $12.54 $250,800 32,000 D
Open-market purchases · 20,000 sh · avg $12.54 · $250,800
Loading xslF345X03/doc4.xml…